First Turn Management LLC's Q3 2024 13F: 13 new positions, 11 exits

Form 13F-HR for the quarter ended Sep 30, 2024 · filed Nov 7, 2024 · 38 reported positions · accession 0001085146-24-005432

What changed this quarter

First Turn Management LLC's changes in reported equity positions, Q3 2024
Activity Security Weight before Weight now Change Shares Shares %
Exited SAREPTA THERAPEUTICS INC (SRPT) 4.7% — −4.7 pts −182K sh −100%
New NATERA INC (NTRA) — 3.1% +3.1 pts +156K sh new
Exited IMMUNOVANT INC (IMVT) 3.0% — −3.0 pts −695K sh −100%
Exited DEXCOM INC (DXCM) 3.0% — −3.0 pts −160K sh −100%
New ARCELLX INC (ACLX) — 2.8% +2.8 pts +214K sh new
New VERONA PHARMA PLC (VRNA) — 2.6% +2.6 pts +573K sh new
New HARROW INC (HROW) — 2.3% +2.3 pts +327K sh new
Exited ALPHATEC HLDGS INC (ATEC) 2.3% — −2.3 pts −1.36M sh −100%
Exited IDEAYA BIOSCIENCES INC (IDYA) 2.3% — −2.3 pts −398K sh −100%
New BICARA THERAPEUTICS INC (BCAX) — 2.3% +2.3 pts +562K sh new
New GERON CORP (GERN) — 2.2% +2.2 pts +3.12M sh new
Reduced ARGENX SE (ARGX) 5.6% 4.7% −0.9 pts −25,538 sh −32%
New ADMA BIOLOGICS INC (ADMA) — 2.1% +2.1 pts +665K sh new
New DAY ONE BIOPHARMACEUTICALS I (DAWN) — 2.1% +2.1 pts +948K sh new
New REPLIGEN CORP (RGEN) — 2.1% +2.1 pts +88,714 sh new
Exited REVOLUTION MEDICINES INC (RVMD) 2.1% — −2.1 pts −330K sh −100%
Exited APOGEE THERAPEUTICS INC (APGE) 2.0% — −2.0 pts −318K sh −100%
New GLAUKOS CORP (GKOS) — 2.0% +2.0 pts +96,097 sh new
Exited SPYRE THERAPEUTICS INC (SYRE) 1.8% — −1.8 pts −464K sh −100%
Increased NUVALENT INC (NUVL) 3.1% 5.8% +2.7 pts +107K sh +42%
Increased SYNDAX PHARMACEUTICALS INC (SNDX) 2.1% 3.6% +1.5 pts +547K sh +85%
Exited SILENCE THERAPEUTICS PLC (SLN) 1.7% — −1.7 pts −537K sh −100%
New BRIDGEBIO PHARMA INC (BBIO) — 1.6% +1.6 pts +400K sh new
Exited IMMUNOCORE HLDGS PLC (IMCR) 1.6% — −1.6 pts −291K sh −100%
New RELAY THERAPEUTICS INC (RLAY) — 1.4% +1.4 pts +1.23M sh new
New ARS PHARMACEUTICALS INC (SPRY) — 1.4% +1.4 pts +593K sh new
Reduced KALVISTA PHARMACEUTICALS INC (KALV) 2.0% 0.7% −1.4 pts −705K sh −66%
Reduced KRYSTAL BIOTECH INC (KRYS) 3.3% 2.0% −1.3 pts −41,280 sh −38%
Reduced AXSOME THERAPEUTICS INC (AXSM) 4.4% 3.6% −0.8 pts −81,952 sh −24%
Reduced VERTEX PHARMACEUTICALS INC (VRTX) 3.9% 2.6% −1.3 pts −15,470 sh −31%
Reduced INTRA-CELLULAR THERAPIES INC (ITCI) 3.9% 3.0% −0.9 pts −92,543 sh −27%
Exited DISC MEDICINE INC (IRON) 1.0% — −1.0 pts −139K sh −100%
Reduced INTUITIVE SURGICAL INC (ISRG) 3.0% 2.4% −0.7 pts −11,647 sh −28%
Reduced VAXCYTE INC (PCVX) 3.2% 3.8% +0.6 pts −48,296 sh −19%
Reduced ASCENDIS PHARMA A/S (ASND) 4.1% 3.6% −0.6 pts −35,988 sh −19%
Increased VERA THERAPEUTICS INC (VERA) 1.3% 2.3% +1.0 pts +114K sh +53%
Reduced TRANSMEDICS GROUP INC (TMDX) 3.4% 2.8% −0.6 pts −25,533 sh −18%
Reduced CYTOKINETICS INC (CYTK) 2.6% 1.9% −0.7 pts −70,171 sh −24%
Increased ENLIVEN THERAPEUTICS INC (ELVN) 1.6% 2.2% +0.6 pts +122K sh +29%
Reduced BIOHAVEN LTD (BHVN) 2.1% 2.5% +0.4 pts −50,203 sh −14%
Increased INSMED INC (INSM) 3.5% 4.1% +0.6 pts +33,091 sh +10%
Reduced MIRUM PHARMACEUTICALS INC (MIRM) 3.9% 4.0% +0.1 pts −55,787 sh −8%
Increased ROCKET PHARMACEUTICALS INC (RCKT) 2.0% 1.8% −0.1 pts +60,317 sh +11%
Reduced CRINETICS PHARMACEUTICALS IN (CRNX) 2.7% 2.9% +0.2 pts −15,926 sh −4%
Reduced MERUS N V (MRUS) 3.1% 2.4% −0.7 pts −13,892 sh −4%
Reduced ORIC PHARMACEUTICALS INC (ORIC) 1.7% 2.4% +0.6 pts −64,923 sh −4%
Reduced XENON PHARMACEUTICALS INC (XENE) 2.2% 2.0% −0.1 pts −14,658 sh −4%
Reduced ESTABLISHMENT LABS HLDGS INC (ESTA) 2.7% 2.4% −0.3 pts −12,977 sh −4%
Reduced BLUEPRINT MEDICINES CORP (BPMC) 3.2% 2.6% −0.6 pts −5,972 sh −3%

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 39.3% of the equity book

Changes in the top 10 this quarter: NUVL entered · PCVX entered · SNDX entered · NTRA entered · SRPT left · VRTX left · TMDX left · KRYS left

# Security Weight before Weight now
1 NUVALENT INC (NUVL) 3.1% 5.8% Entered the top 10
2 ARGENX SE (ARGX) 5.6% 4.7%
3 INSMED INC (INSM) 3.5% 4.1%
4 MIRUM PHARMACEUTICALS INC (MIRM) 3.9% 4.0%
5 VAXCYTE INC (PCVX) 3.2% 3.8% Entered the top 10
6 AXSOME THERAPEUTICS INC (AXSM) 4.4% 3.6%
7 SYNDAX PHARMACEUTICALS INC (SNDX) 2.1% 3.6% Entered the top 10
8 ASCENDIS PHARMA A/S (ASND) 4.1% 3.6%
9 NATERA INC (NTRA) 0.0% 3.1% Entered the top 10
10 INTRA-CELLULAR THERAPIES INC (ITCI) 3.9% 3.0%
— SAREPTA THERAPEUTICS INC (SRPT) 4.7% 0.0% Left the top 10
— VERTEX PHARMACEUTICALS INC (VRTX) 3.9% 2.6% Left the top 10
— TRANSMEDICS GROUP INC (TMDX) 3.4% 2.8% Left the top 10
— KRYSTAL BIOTECH INC (KRYS) 3.3% 2.0% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).